Neil Elliot Kay, MD

  • 20083 Citations
  • 75 Scopus h-Index
1973 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Comment/debate
Comment/debate

Angiogenesis in B-chronic lymphocytic leukemia

Kay, N. E., Jelinek, D. F. & Peterson, L. A., Jun 11 2001, In : Leukemia Research. 25, 8, p. 709-710 2 p.

Research output: Contribution to journalComment/debate

12 Scopus citations

Angiogenesis in B-chronic lymphocytic leukemia

Kay, N. E., Jelinek, D. F. & Peterson, L. A., May 15 2001, In : Leukemia Research. 25, 6, p. 485-486 2 p.

Research output: Contribution to journalComment/debate

1 Scopus citations

B-CLL: is the enigma of disease heterogeneity about to be revealed?

Kay, N. E. & Jelinek, D. F., Aug 15 2002, In : Blood. 100, 4, p. 1110-1111 2 p.

Research output: Contribution to journalComment/debate

9 Scopus citations

Chemoimmunotherapy is not dead yet in chronic lymphocytic leukemia

Brown, J. R. & Kay, N. E., Sep 10 2017, In : Journal of Clinical Oncology. 35, 26, p. 2989-2992 4 p.

Research output: Contribution to journalComment/debate

9 Scopus citations

Circulating endothelial cells in chronic lymphocytic leukemia: More evidence of disturbed angiogenesis

Kay, N. E., Feb 6 2009, In : Leukemia and Lymphoma. 50, 1, p. 8-9 2 p.

Research output: Contribution to journalComment/debate

1 Scopus citations

Combination therapies for previously untreated CLL

Shanafelt, T. D. & Kay, N. E., Jul 21 2007, In : Lancet. 370, 9583, p. 197-198 2 p.

Research output: Contribution to journalComment/debate

2 Scopus citations

Correction to Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): Enhancing apoptosis [J Nanobiotechnol 5 (2007) 4]

Mukherjee, P., Bhattacharya, R., Bone, N., Lee, Y. K., Patra, C. R., Wang, S., Lu, L., Secreto, C., Banerjee, P. C., Yaszemski, M. J., Kay, N. E. & Mukhopadhyay, D., Jul 1 2013, In : Journal of Nanobiotechnology. 11, 1, 23.

Research output: Contribution to journalComment/debate

2 Scopus citations

Erratum: VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: Implication for apoptosis resistance (Leukemia (2005) 19 (513-523) doi:10.1038/sj.leu.2403667)

Lee, Y. K., Shanafelt, T. D., Bone, N. D., Strege, A. K., Jelinek, D. F. & Kay, N. E., Jan 1 2010, In : Leukemia. 24, 4, 1 p.

Research output: Contribution to journalComment/debate

Novel targeted agents and the need to refine clinical end points in chronic lymphocytic leukemia

Cheson, B. D., Byrd, J. C., Rai, K. R., Kay, N. E., O'Brien, S. M., Flinn, I. W., Wiestner, A. & Kipps, T. J., Aug 22 2012, In : Journal of Clinical Oncology. 30, 23, p. 2820-2822 3 p.

Research output: Contribution to journalComment/debate

141 Scopus citations

p53 activation comes to the rescue in CLL

Kay, N. E., May 15 2006, In : Blood. 107, 10, p. 3815-3816 2 p.

Research output: Contribution to journalComment/debate

Reconstitution of innate immunity in B-chronic lymphocytic leukemia: Time to reconsider the possibilities

Lee, Y. K. & Kay, N. E., Oct 2003, In : Leukemia. 17, 10, p. 1945-1947 3 p.

Research output: Contribution to journalComment/debate

Survival of chronic lymphocytic leukemia cells: CD40L and the vascular endothelial growth factor (VEGF) connection

Kay, N. E. & Wasil, T., Apr 2005, In : Leukemia. 19, 4, p. 531-532 2 p.

Research output: Contribution to journalComment/debate

3 Scopus citations

T-cell abnormalities in patients with chronic lymphocytic leukemia

Shanafelt, T. & Kay, N., Jul 1 2006, In : Leukemia and Lymphoma. 47, 7, p. 1197-1198 2 p.

Research output: Contribution to journalComment/debate

2 Scopus citations

The yin and yang of lenalidomide

Kay, N. E., Dec 15 2008, In : Blood. 112, 13, p. 4785-4786 2 p.

Research output: Contribution to journalComment/debate

1 Scopus citations